Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:30 AM
Ignite Modification Date:
2025-12-25 @ 4:30 AM
NCT ID:
NCT02367118
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of CRSsNP as recommended European Position Paper on Rhinosinusitis and Nasal Polyps 2012
Exclusion Criteria:
* Treatment with oral corticosteroids or topical corticosteroids the last 4 weeks.
* Previous surgical treatment for CRSsNP
* History of diabetes mellitus and / or glaucoma and / or decompensated hypertension and / or gastric ulcer.
* Pregnancy.
* History of cystic fibrosis, primary ciliary dyskinesia, immunodeficiency, allergic fungal sinusitis, nasal polyps, nasal tumors, hepatic or renal dysfunction.
* Hypersensitivity to prednisone
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02367118
Study Brief:
Protocol Section:
NCT02367118